scholarly article | Q13442814 |
P2093 | author name string | P Zhang | |
M Li | |||
Y Li | |||
J Zhou | |||
Y Feng | |||
Y Xie | |||
J Xue | |||
L Xiao | |||
X Kong | |||
S Cheng | |||
G Yao | |||
N Geng | |||
P2860 | cites work | Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs | Q24302072 |
Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly | Q24313436 | ||
A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis | Q24323178 | ||
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA | Q24336971 | ||
The promises and pitfalls of RNA-interference-based therapeutics | Q24657247 | ||
The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression | Q24797652 | ||
siRNAdb: a database of siRNA sequences | Q24797923 | ||
Inducible, reversible, and stable RNA interference in mammalian cells | Q36604113 | ||
Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells | Q36854864 | ||
Strategies targeting telomerase inhibition | Q37067685 | ||
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. | Q38329911 | ||
Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity | Q38331538 | ||
Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity | Q39832411 | ||
VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent | Q40121812 | ||
Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA. | Q40137267 | ||
Silencing of HIV-1 with RNA interference: a multiple shRNA approach | Q40234514 | ||
Adenovirus-mediated small-interference RNA for in vivo silencing of angiotensin AT1a receptors in mouse brain | Q40335621 | ||
Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length-independent pathway | Q40365444 | ||
Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). | Q40428170 | ||
An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans | Q40522098 | ||
Clinical significance and usefulness of quantification of telomerase activity in oral malignant and nonmalignant lesions | Q80507936 | ||
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases | Q81506939 | ||
P433 | issue | 5 | |
P304 | page(s) | 318-325 | |
P577 | publication date | 2011-01-14 | |
P1433 | published in | Cancer Gene Therapy | Q15763088 |
P1476 | title | Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma | |
P478 | volume | 18 |
Q35125619 | Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line |
Q47829840 | MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. |
Q28542909 | Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo |
Q37610098 | Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity |
Q64885984 | Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases. |
Q47964963 | shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells |
Search more.